Medical genetics-based drug repurposing for Alzheimer's disease

This publication has 46 references indexed in Scilit:

• Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
  Current Topics in Medicinal Chemistry, 2013
• ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease
  International Journal of Molecular Sciences, 2013
• National estimates of the prevalence of Alzheimer's disease in the United States
  Alzheimer's & Dementia, 2011
• Lipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer Dementias
  Neurochemical Research, 2007
• Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
  Nature Genetics, 2007
• Human monogenic disorders — a source of novel drug targets
  Nature Reviews Genetics, 2006
• Drug repositioning: identifying and developing new uses for existing drugs
  Nature Reviews Drug Discovery, 2004
• The angiotensin converting enzyme (ACE)
  The International Journal of Biochemistry & Cell Biology, 2003
• Angiofensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease
  European Journal of Pharmacology, 1991
• Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas
  Journal of Neurochemistry, 1982